Solana Co

Solana Co(HSDT)の株式分析

$1.930

-0.156 (-8.10%)終値時点

Loading chart…
高値
2.100
始値
2.100
出来高加重平均価格
1.96
出来高
601.53K
時価総額
2.91M
安値
1.850
売買代金
1.18M
EV/EBITDA(TTM)
-0.75

Solana Company, formerly Helius Medical Technologies, Inc., is a digital asset treasury dedicated to acquiring Solana (SOL), created in partnership with Pantera and Summer Capital. It is focused on maximizing SOL per share by leveraging capital markets opportunities and on chain activity. It offers public market investors optimal exposure to Solana’s secular growth. It has adopted a digital asset treasury strategy focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises that produce consistent on-chain yield generation. It will provide access to the Solana network. Solana DAT provides access to the blockchain market to a new kind of investor. As a global capital markets onramp, HSDT channels liquidity into the Solana ecosystem, strengthening network security and fueling on chain activity, creating a virtuous cycle that delivers value back to shareholders.

www.solanacompany.co

AI分析 of Solana Co (HSDT)

売り

Helius Medical Technologies Inc (HSDT) is not a good buy right now due to its current price of $2.015 and a very low RSI of 21.258, indicating oversold conditions. The stock has also seen a significant decline of 55.71% over the past year, which raises concerns about its long-term viability. While the forward P/E is 0, suggesting potential for future earnings, the recent performance and negative sentiment surrounding the stock indicate that it may not be a suitable investment at this time.

アナリスト評価(1)

買い
1 買い
0 中立
0 売り
現在: 1.93
安値
—
平均
—
高値
—

B. Riley

2026-09-22

目標株価

$4

買い

B. Riley

2026-09-03

目標株価

—

買い

B. Riley

2026-04-23

目標株価

$3

買い

Maxim Group

2024-10-16

目標株価

—

中立

Roth MKM

2024-03-05

目標株価

$24

強い買い

バリュエーション指標

Solana Co(HSDT)の現在の予想PERは0.00で、5年平均は-2.35です。

予想PER

適正
5年平均 P/E
-2.35
現在のP/E
0.00
割高
4.42
割安
-9.13

予想EV/EBITDA

適正
5年平均 EV/EBITDA
-0.93
現在のEV/EBITDA
-0.75
割高
12.80
割安
-14.66

予想PSR

適正
5年平均 P/S
48.77
現在のP/S
9.87
割高
224.58
割安
-127.04

Alphio AI による HSDT の価格シナリオ

シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

強

強気

強気 · 25%HSDT

$2.58

シナリオ価格

基

基本

基本 · 50%HSDT

$2.40

シナリオ価格

弱

弱気

弱気 · 25%HSDT

$2.06

シナリオ価格

HSDT を保有するクジラ

V

VR Advisory Services Ltd.

+ を保有HSDT

+0.00%

3か月リターン

イベントタイムライン

2026-10-23 (ET)

10:00:00

Webull to Launch Crypto-Linked Perpetual Futures in November

2026-10-22 (ET)

09:30:00

Solana Company Designated as Strategic Enterprise by Hong Kong Government

2026-09-25 (ET)

10:00:00

Binance Invests $100M in Circle to Boost USDC Development

2026-09-04 (ET)

10:30:00

Coinbase Files for U.S. Derivatives Registration

2026-06-30 (ET)

07:30:00

Solana Signs MoU with Alatau City for Blockchain Partnership

ニュース

HSDT のよくある質問 — Alphio AI が回答

Solana Company, formerly Helius Medical Technologies, Inc., is a digital asset treasury dedicated to acquiring Solana (SOL), created in partnership with Pantera and Summer Capital. It is focused on maximizing SOL per share by leveraging capital markets opportunities and on chain activity. It offers public market investors optimal exposure to Solana’s secular growth. It has adopted a digital asset treasury strategy focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises that produce consistent on-chain yield generation. It will provide access to the Solana network. Solana DAT provides access to the blockchain market to a new kind of investor. As a global capital markets onramp, HSDT channels liquidity into the Solana ecosystem, strengthening network security and fueling on chain activity, creating a virtuous cycle that delivers value back to shareholders. It operates in the Financials sector (ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry).

Helius Medical Technologies Inc (HSDT) is not a good buy right now due to its current price of $2.015 and a very low RSI of 21.258, indicating oversold conditions. The stock has also seen a significant decline of 55.71% over the past year, which raises concerns about its long-term viability. While the forward P/E is 0, suggesting potential for future earnings, the recent performance and negative sentiment surrounding the stock indicate that it may not be a suitable investment at this time.

1 analysts cover HSDT: 1 rate it Buy, 0 Hold and 0 Sell.

コミュニティ

もっと見る ↗

投稿はまだありません

登録またはログインして議論に参加

関連記事

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める